(RDHL) Redhill Biopharma complete technical analysis [charts+indicators] | Buy/Sell Redhill Biopharma | (RDHL) share price targets
Complete technical analysis of Redhill Biopharma (RDHL) by charts plus indicators, forecast predictions and share price targets for Redhill Biopharma (RDHL)
Redhill Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2026-01-05 View latest technical analysis
10 day averaged volume of Redhill Biopharma is 85881
| Date | Daily Closing Price | Open | High | Low | Volume |
| 05 Mon Jan 2026 | 1.40 | 1.20 | 1.42 | 1.19 | 287.587 times |
| 02 Fri Jan 2026 | 1.03 | 1.04 | 1.06 | 1.02 | 0.384 times |
| 31 Wed Dec 2025 | 1.03 | 1.01 | 1.04 | 0.91 | 3.609 times |
| 30 Tue Dec 2025 | 1.03 | 1.06 | 1.08 | 1.03 | 0.732 times |
| 29 Mon Dec 2025 | 1.09 | 1.11 | 1.15 | 1.06 | 0.696 times |
| 26 Fri Dec 2025 | 1.14 | 1.18 | 1.18 | 1.13 | 0.299 times |
| 24 Wed Dec 2025 | 1.15 | 1.18 | 1.21 | 1.15 | 0.844 times |
| 23 Tue Dec 2025 | 1.18 | 1.10 | 1.23 | 1.10 | 2.33 times |
| 22 Mon Dec 2025 | 1.15 | 1.14 | 1.18 | 1.14 | 0.267 times |
| 19 Fri Dec 2025 | 1.18 | 1.18 | 1.20 | 1.17 | 0.236 times |
Stock of Redhill Biopharma (RDHL) has showed a significant upmove. This could be a good time to enter in this stock!
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 1.3, for a target of 1.3 or 1.17
Share price targets for Redhill Biopharma (RDHL)
| Target Type | Value |
| Downside Target | 0.91 |
| Downside Target | 1.01 |
| Downside Target | 1.10 |
| Downside Target | 1.14 |
| Downside Target | 1.19 |
| Downside Target | 1.22 |
| Downside Target | 1.26 |
| Downside Target | 1.30 |
| Upside Target | 1.42 |
| Upside Target | 1.68 |
| Upside Target | 2.79 |
| Upside Target | 3.04 |
Intraday share price targets for Redhill Biopharma (RDHL)
| Target Type | Value |
| Downside Intraday Target | 1.25 |
| Downside Intraday Target | 1.11 |
| Upside Intraday Target | 1.48 |
| Upside Intraday Target | 1.57 |
| Downside Intraday Target | 1.34 |
Weekly technical analysis of Redhill Biopharma (RDHL)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 05 Mon Jan 2026 | 1.40 | 1.20 | 1.42 | 1.19 | 53.046 times |
| 02 Fri Jan 2026 | 1.03 | 1.11 | 1.15 | 0.91 | 1.45 times |
| 26 Fri Dec 2025 | 1.14 | 1.14 | 1.23 | 1.10 | 0.904 times |
| 19 Fri Dec 2025 | 1.18 | 1.22 | 1.24 | 1.14 | 1.648 times |
| 12 Fri Dec 2025 | 1.21 | 1.19 | 1.26 | 1.16 | 0.638 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Redhill Biopharma (RDHL)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 05 Mon Jan 2026 | 1.40 | 1.04 | 1.42 | 1.02 | 14.871 times |
| 31 Wed Dec 2025 | 1.03 | 1.20 | 1.26 | 0.91 | 0.058 times |
| 28 Fri Nov 2025 | 1.20 | 1.24 | 1.68 | 1.01 | 1.116 times |
| 31 Fri Oct 2025 | 1.30 | 2.23 | 3.04 | 1.30 | 0.446 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Redhill Biopharma (RDHL)
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Redhill Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Redhill Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Redhill Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Redhill Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Redhill Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.39 and Redhill Biopharma (RDHL) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Redhill Biopharma (RDHL) stock. Volume based technical analysis of Redhill Biopharma (RDHL) stock is negative.
Redhill Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Redhill Biopharma ( (RDHL) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Redhill Biopharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Redhill Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Redhill Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Redhill Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Redhill Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.39 and Redhill Biopharma (RDHL) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Redhill Biopharma (RDHL) stock. Volume based technical analysis of Redhill Biopharma (RDHL) stock is negative.
Redhill Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.